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Introduction: 
 
Notch Signaling in the Vasculature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
The Notch Signaling Pathway  
 The Notch signaling pathway plays a role in vascular development and 
physiology, including a pivotal role in the regulation of vascular smooth muscle cell 
phenotypes1. Notch receptors are evolutionarily conserved cell surface receptors that 
interact with ligands on nearby cells via direct cell-to-cell contact2,3. Mammals express 
four Notch receptors (Notch1-4) and five Notch ligands (Jagged1 and 2, Delta-like 
ligand 1, 3, and 4). Both ligands and receptors are Type-1 transmembrane proteins 
containing long extracellular domains consisting of epidermal growth-factor like repeats. 
The extracellular domain serves as a binding platform and is the site of receptor-ligand 
interactions. In the vasculature, Notch2 and Notch3 in smooth muscle cells and 
Jagged1 in endothelial cells are the predominantly expressed receptors and ligands, 
respectively4,5.  
The Notch signaling pathway operates through juxtacrine signaling. Ligands 
present on the cell membrane of endothelial cells interact with Notch receptors located 
on the cell membrane of smooth muscle cells. Ligand- receptor interactions result in 
proteolytic cleavage of the Notch intracellular signaling domain catalyzed by the gamma 
secretase complex. Cleavage frees the Notch intracellular signaling domain which, due 
to the presence of a nuclear localization signal, translocates to the nucleus. Nuclear 
translocation of the intracellular signaling domain results in the formation of a complex 
with the RBPJ DNA binding protein; this formation process displaces the transcriptional 
repressors Ski-interacting protein, CBF1-interacting corepressor, KyoT2, SMRT-and 
HDAC-associated repressor, and histone deacetylases6. The resulting Notch 
intracellular signaling domain-RBPJ complex can then recruit transcriptional activators 
such like MAML1 and acetyltransferase to activate the expression of Notch target 
genes. Thus, the Notch intracellular signaling domain acts as a transcriptional co-factor. 
Notch-activated genes that are 
highly expressed include beta helix-
loop-helix proteins like those of the 
HES/ HEY family which act as 
transcriptional repressors7.  
 The cardiovascular system 
consists of the heart and an 
expansive network of blood 
vessels8. Blood vessels in the 
cardiovascular system are composed of an inner endothelial cell tube surrounded by 
one or more layers of vascular smooth muscle cells. Endothelial cells regulate the 
exchange between the bloodstream and surrounding tissues. Endothelial cells also 
translate hemodynamic cues into signals sent to smooth muscle cells, which then 
respond accordingly – by constriction or dilation8.   
Communication between endothelial cells and smooth muscle cells is vital for 
proper formation and function of the vasculature, and the Notch signaling pathway is 
one such method of communication. Generally, the roles of Notch signaling include 
regulation of artery-vein specification and differentiation, regulation of endothelial tip cell 
differentiation during angiogenesis, influence over tumor angiogenesis, and regulation 
of physiological responses of vascular smooth muscle cells9. Mutations of components 
of the Notch signaling pathway have also been associated with a myriad of diseases 
Figure 1. Depiction of the canonical Notch signaling 
pathway.  
including Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy, Alagille Syndrome, Infantile myofibromatosis, and childhood 
pulmonary arterial hypertension10–16. Most pertinent to the current study is the role of 
Notch signaling in controlling vascular smooth muscle cell phenotypes. Vascular smooth 
muscle cells serve to control blood flow and regulate vessel permeability, among other 
functions. For example, endothelial cells respond to hemodynamic cues and signal 
smooth muscle cells to contract or dilate accordingly. Uniquely, vascular smooth muscle 
cells are not terminally differentiated. Rather, these cells can adapt their expression 
patterns and resultant activities in response to a variety of cues. The ability of vascular 
smooth muscle cells to have a variety of different functions in response to external cues 
is known as phenotype switching or plasticity17–19.  
 In adult mammals, the vasculature must actively maintain homeostasis as well as 
be able to respond to vascular injury. Plasticity of vascular smooth muscle cells, as 
regulated at least in part by the Notch signaling pathway, is key to homeostasis and 
injury response in the vasculature. There is a spectrum of states in which the vascular 
smooth muscle cell can exist in order to achieve proper vessel function. A differentiated 
smooth muscle cell is thought to express contractile proteins and to be quiescent. A 
proliferative vascular smooth muscle cells is mitotically active and is nominally 
considered dedifferentiated17. The synthetic vascular smooth muscle cell is 
characterized by its contribution to extracellular matrix synthesis through production of 
proteins such as collagen20,21. Notch signaling also influences vascular smooth muscle 
cell survival and apoptosis in response to stressors as well as migration during vessel 
development and response to vascular injury1,22. The current study will investigate how 
the protein Cytoglobin and the micro RNA miR-145 are regulated by the Notch signaling 
pathway to influence vascular smooth muscle cell phenotype and contribute to 
cardiovascular form and function.  
Cytoglobin  
 Cytoglobin is a hexacoordinate hemoglobin that is widely expressed in a myriad 
of tissues. As a member of the globin family, it is able to bind gaseous ligands such as 
oxygen, carbon monoxide, and nitric oxide. The ability to bind gaseous ligands, much 
like the other globin family members hemoglobin and myoglobin, suggests an important 
role for Cytoglobin in maintaining cellular homeostasis. Cytoglobin has recently been 
implicated in vascular function and stress regulation, and has potential roles in the 
modulation of nitric oxide metabolism. Nitric oxide is central to maintaining normal blood 
vessel physiology via its role in regulating smooth muscle cells tone, signaling between 
endothelial cells and smooth muscle cells, and conducting physiological responses.  
Given the potential implications of Cytoglobin in vascular smooth muscle cell function, 
this study sought to examine the regulation and function of Cytoglobin. We identified 
Cytoglobin as a gene induced in vascular smooth muscle cells by co-cultured 
endothelial cells. Our data show that Cytoglobin expression is induced in smooth 
muscle cells through endothelial cell-dependent Notch signaling and that smooth 
muscle cell receptors are necessary for Cytoglobin expression. Examining the function 
of Cytoglobin in smooth muscle cells indicates a link to managing vascular-derived 
stress. Our findings support the notion that endothelial cells induce Cytoglobin 
expression in smooth muscle cells as a means to regulate nitric oxide bioavailability in 
blood vessels. In all, our results reveal a novel mechanism in which Notch signaling 
contributes to vascular function through regulation of a gene implicated in nitric oxide 
availability.  
miR-145  
 
 Cardiac fibrosis, or cardiac scar tissue, develops as a result of unremitting, 
pathological tissue repair following cardiovascular insult or injury. Nearly all forms of 
cardiovascular disease are associated with cardiac fibrosis. A major cellular player in 
cardiac fibrosis is the cardiac fibroblast. The cardiac fibroblast is a major cell type in the 
heart that provides structural support and works to maintain homeostasis of the 
myocardial extracellular matrix. Upon stress, injury, environmental stimuli, or pressure 
overload, the cardiac fibroblast is activated and transdifferentiates into the 
myofibroblast. Myofibroblasts secrete and remodel the extracellular matrix as a part of a 
normal healing regime after cardiac injury or insult. When myofibroblasts accumulate, 
persist, and deposit excessive extracellular matrix, the process becomes pathological 
leading to fibrosis and progression of heart disease. Several signaling pathways have 
been implicated in myofibroblast activation. We propose that miR-145 functions in 
cardiac fibroblasts to suppress cardiac fibrosis by inhibiting various mediators of the 
fibrotic cellular phenotype such as Transforming Growth Factor Beta (TGF-ß) and p38 
Mitogen Activated Protein Kinase Signaling (MAPK). Interest in miR-145’s role in 
cardiac fibrosis developed in the Lilly Lab as a result of findings demonstrating that loss 
of miR-145 exacerbates angiotensin II-induced fibrosis. These studies focused on miR-
145 expression in smooth muscle cells. Induction of miR-145 in smooth muscle cells 
occurred upon co-culture with endothelial cells, was augmented by Notch signaling, and 
was reduced in Notch receptor deficient cells. The current study seeks to characterize 
the phenotype of novel RFP-miR-145 transgenic mice, which will enable the studied 
mice strains to be used to study the role that miR-145 plays in modulating cardiac 
fibrosis via posttranscriptional regulation the cardiac fibroblast.   
 
Cytoglobin Expression is Induced in Vascular 
Smooth Muscle Cells Through Endothelial 
Derived Notch Signaling: 
 
Implications of a Protective Role in Blood Vessel Function   
Introduction  
 
Cytoglobin, so named for its ubiquitous expression in a variety of tissues23, is the 
newest member of the globin family, a class of proteins implicated in the storage and 
transportation of oxygen. Specifically, Cytoglobin is a hexacoordinate heme protein with 
the ability to bind gaseous ligands such as oxygen, nitric oxide, and carbon monoxide. It 
is detected ubiquitously in a variety of tissues, but it is predominantly found in fibroblast-
related cell lineages24–26. Primarily, Cytoglobin is a cytoplasmic protein, although it has 
been detected in the nucleus as well27. Although the precise functional role of 
Cytoglobin is not yet well defined, the hemoprotein is generally thought to play a 
cytoprotective role, participating in oxygen storage and transport and nitric oxide 
scavenging to protect the cell from oxidative stress28. Cytoglobin has been found to be a 
stress related gene that is up-regulated during oxidative stress. Additionally, it is known 
that Cytoglobin protects cells from injury induced by oxidative stress and from the 
harmful consequences of excess reactive oxygen species in the cell23.   
Several diseases have been associated with Cytoglobin, including multiple 
modalities of vascular injury, fibrosis, and cancer29–32. In vascular injury models, it has 
been demonstrated that Cytoglobin regulates the hyperplastic response(1) by providing 
protection from unnecessary programmed cell death through a redox sensitive signaling 
network30. Further, Cytoglobin is implicated in the regulation of vascular tone through its 
activity as an NO dioxygenase(2) and through its role in the management of NO 
metabolism31. Supporting Cytoglobin’s connection to NO and ROS, Cytoglobin knockout 
																																																						
(1) Hyperplasia is an increase in the number of normal cells in a tissue or organ.  
(2) An enzyme that catalyzes the conversion of nitric oxide to nitrate.  
mice experienced multiple spontaneous organ abnormalities in both young and aged 
mice along with increased NO metabolites and ROS production in the serum32. The 
apparent ability of Cytoglobin to regulate the consumption and metabolism of NO and 
ROS indicates an important role for the hemoprotein in vascular homeostasis that could 
have clinical implications and calls for a closer look at its regulation.  
Cytoglobin is widely expressed, but evidence indicates that its expression is 
tightly regulated and responds to environmental cues. Analyses of the Cytoglobin 
promoter region reveal that a GC rich promoter region is located between -1113 and -10 
relative to the translation start site. The promoter region contains binding sites for c-Ets-
1 and Sp1. C-Ets-1 is a member of the Ets family and plays a critical role in the gene 
expression regulation and development of hematopoietic cells. Sp1 is member of family 
of proteins that are essential for transcription activation and therefore expression 
regulation of housekeeping, tissue specific and viral genes33. Further investigation of 
Cytoglobin’s promoter region resulted in the identification of hypoxia response element 
motifs in the 5’ untranslated region. Hypoxia-inducible factor-1 (HIF-1) is able to bind to 
this hypoxia response element. Under hypoxic conditions, the HIF-1a protein is 
stabilized, allowing it to bind to HIF-1b and form the HIF-1 transcription complex. It is 
these elements rather than the c-Ets-1 and Sp1 elements that are proposed to be 
responsible for the activation of Cytoglobin expression under hypoxic conditions34.  
 Other reports demonstrate that Cytoglobin is transcriptionally regulated by 
oxidative stress, with upregulation occurring under hypoxic conditions possibly mediated 
by the HIF-1a transcription factor23,35. HIF-1a, along with other transcription factors such 
as AP-1 and NFAT, has an evolutionarily conserved binding element in the upstream 
region of the Cytoglobin gene, indicating a role in regulation. AP-1 and NFAT 
transcription factors are linked to calcineurin, a calcium-calmodulin activated 
phosphatase involved in the signaling pathways that regulate cardiac genes and 
subsequent processes such as cardiac remodeling, hypertrophy, apoptosis and 
metabolism. Both hypoxia and manipulations of calcineurin alter AP-1 and NFAT 
interactions with Cytoglobin resulting in modulation of its expression36. Cytoglobin has 
also been shown to be transcriptionally regulated by ∆Np63, an indispensable factor for 
maintaining a cell’s proliferative abilities37. 
 Beyond transcriptional regulation, Cytoglobin expression has been found to be 
under the influence of growth factors as well. One such growth factor is fibroblast 
growth factor 2, which was demonstrated to be a strong inducer of Cytoglobin 
expression in hepatic stellate cells38. Returning to the vasculature, Cytoglobin is 
expressed in mature smooth muscle cells. Interestingly, Cytoglobin is expressed in 
contractile smooth muscle cells but experiences downregulation upon 
dedifferentiation30. Despite evidence of these expression patterns in vascular smooth 
muscle cells, vasculature-specific transcriptional mediators have not been thoroughly 
investigated.  
 The vasculature is comprised of two different types of cells, endothelial cells and 
smooth muscle cells. Proper communication between these cells is vital for ensuring 
correct blood vessel function and formation throughout development and into 
adulthood39,40. The Lilly Lab has extensively studies this communication and has 
demonstrated that the Notch signaling pathway plays a key role in smooth muscle cell-
endothelial cell interaction. In vitro assays done in the lab show that the Notch signaling 
pathways is activated in smooth muscle cells cocultured with endothelial cells. Various 
proteins have been identified as being upregulated under these coculture conditions as 
well. Cytoglobin is one such protein. This project sought to test the central hypothesis 
that Cytoglobin is regulated by Notch signaling and functions in vascular homeostasis. 
Evaluation of the function and regulation of Cytoglobin will contribute to the current 
understanding of cellular communication mechanisms and consequences in the 
vasculature and may provide new insight into therapies for vascular diseases.  
 Specifically, the current study aims to investigate the regulation of Cytoglobin by 
the interactions of endothelial and smooth muscle cells. The role of the Notch signaling 
pathway on Cytoglobin expression in smooth muscle cells via endothelial cells contact 
is directly tested. In addition, the function of Cytoglobin in vascular smooth muscle cells 
is explored.  
 In this study, we demonstrate that Cytoglobin expression is induced in smooth 
muscle cells by endothelial cells in coculture. We further demonstrate that the 
endothelial dependent induction of Cytoglobin is dependent on the Notch signaling 
pathway and Notch signaling is required to maintain Cytoglobin expression in smooth 
muscle cells. Additionally, we show that Cytoglobin is linked to hypoxia as is consistent 
with previous research, and that modulation of Cytoglobin levels can result in the 
modulation of nitric oxide levels in the cell. Taken together, these data uncover a novel 
mechanism by which endothelial cells regulate the expression of Cytoglobin in smooth 
muscle cells, and reveal a putative function for this regulation – influencing smooth 
muscle cell function via mediators of vascular reactivity. 
 
Materials and Methods  
Cell Culture  
Primary cultures of human aortic smooth muscle cells (HAoSMCs) and human 
coronary artery smooth muscle cells were purchased from Lonza and grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Inc.) and were 
supplemented with 5% fetal bovine serum (FBS) (Hyclone), 2mM glutamine, 1 mM 
sodium pyruvate and 100 U/ml penicillin-streptomycin. Human aortic endothelial cells 
(HAECs) and human coronary artery endothelial cells (HCAECs) were purchased from 
Lonza and cultured in EBM-2 supplemented with the bullet kit as recommended 
(Lonza). Primary cells between passages 6 and 10 were used for all experiments. All 
cultures were maintained in a humidified 5% CO2 incubator at 37°C.  
For coculture smooth muscle cells were plated at a density of 1 x 105 cells/ well 
in a 6-well plate or at a density of 5 x 104 cells/ well in 12-well dish. After adhesion, 
endothelial cells were added at 1 x 105 cells/ well in a 6-well plate or at 5 x 105 cells/ 
well in a 12- well plate. Cells were then incubated 24 to 48 hours prior to cell separation 
and processing. All co-culture and alone control experiments were conducted in EBM-2 
media supplemented with the bullet kit. To separate HAoSMCs from HAECs, anti-
PECAM1-conjugated Dynabeads (Invitrogen) were used according to the 
manufacturer’s instructions40. All co-culture experiments were performed in EBM-2 
media supplemented with the bullet kit. Notch Inhibitor, DAPT (N-[(3,5-
Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethylethyl ester, Calbiochem) 
was added to specified wells after cell adhesion. Donor was added to specified wells at 
a final concentration of 0.05 micromolar; CPITO, an NO inhibitor, at 0.013 micromolar; 
H2O2 at 0.1 micromolar; and CoCl2, a hypoxia mimic, at 0.05 micromolar.  
Quantitative Real-Time PCR (qPCR) 
Total RNA was isolated from cells using RiboZol RNA Extraction Reagent 
(Ampresco) according to the manufacturer’s instructions. RNA was reverse transcribed 
with M-MLV Reverse Transcriptase (Promega) to generate cDNA. Real-Time PCR was 
performed using the StepOne Real Time PCR system by Applied Biosystems. The 
reporter dye was the Power SYBR Green PCR Mastermix and 50 ng of cDNA template 
was used. The fold difference in mRNA levels of the target gene was calculated using 
the ∆∆CT method with normalization to RPL13A mRNA levels. The following are the 
primer sequences: CYGB, 5’-AAC ACT GTC GTG GAG AAC CTG CAT -3’ (forward) 
and 5’ –TGA AGT ACA CCG GTT CCA CCT TGT -5’ (reverse); NOTCH3, 5’- GAG CCA 
ATG CCA ACT GAA GAG -3’ (forward) and 5’-GGC AGA TCA GGT CGG AGA TG -3’ 
(reverse); NOTCH2, 5’-ACA GTT GTG TCT GCT CAC CAG GAT -3’ (forward) and 5’-
GCG GAA ACC ATT CAC ACC GTT GAT -3’ (reverse); RPL1A, 5’-CTT GTG AGT 
GGG GCA TCT G -3’ (forward) and 5’- CCC TGT GTA CAA CAG CAA GC -3’ (reverse); 
NOX4, 5’ –CTGCTGACGTTGCATGTTTC – 3’ (forward) and 5’-
CTGAGAGCTGGTTCGGTTAAG -3’ (reverse).  
siRNA Transfection  
HAoSMCs were plated in either a 6-well plate at 1 x 105 cell/ well or in a 12-well 
plate at 5 x 104 cells/well. After 24 hours, cells were transfected with siRNA using 
Lipofectamine RNAiMAX (Invitrogen). Efficiency of knockdown was assessed using 
qPCR and Western Blot. Control Silencer Select Negative Control siRNA was 
purchased from Invitrogen. NOTCH3 siRNA was synthesized by IDT: 5’-AAC UGC GAA 
GUG AAC AUU G, and used as previously described. NOTCH2 siRNA was purchased 
from Qiagen (Assay ID:GS4853) and CYGB siRNA from ThermoFisher (Assay 
ID:s41571).  All siRNAs were transfected at 100 nM. After a 24-hour transfection period, 
cells were co-cultured with endothelial cells for 48 hours, separated, and collected for 
qPCR analysis and Western blotting.  
Western Blotting  
Cells were homogenized with RIPA buffer containing 50 mM Tris-Cl, pH 7.4, 150 
mM NaCl, 1% Nonidet P-40, 0.25% SDS, and protease inhibitors (Sigma). Protein 
concentrations were determined using the Pierce BCA Protein Assay Kit (Fischer). 
Equal amounts of total cellular protein were loaded onto a 12.5% SDS-Polyacrylamide 
(SDS-PAGE) gels and were transferred to nitrocellulose blotting membranes (GE 
Healthcare). Membranes were incubated for 1 hour at room temperature in 5% nonfat 
dry milk in 1x PBS. Membranes were then incubated overnight at 4° C with primary 
antibody against CYGB (Rabbit PolyAb Anti-CYGB, 1:1000) (Proteintech 13317-1-AP) 
in 2.5% nonfat dry milk in 1x PBS. Membranes were incubated for one hour at room 
temperature with primary antibody against b-TUBULIN 1 (Mouse Anti-tubulin, 1:20,000) 
(Sigma, T7816). Secondary antibodies were incubated 1 hour at room temperature 
(Donkey anti-Rabbit IR-Dye 680RD, Donkey anti-Mouse IR-Dye 800CW; LI-COR). 
Proteins were detected by LI-COR Odyssey Infrared Imaging System and quantified 
using Image Studio Software by normalizing to b-TUBULIN 1 expression.  
 
 
Statistical Analysis  
Data analyses were performed using GraphPad Prism. Comparisons between 
data set were made using One-way ANOVA. Differences with P < 0.05 were considered 
significant. Data are representative of at least three independent experiments.  
Results  
 
Cytoglobin is Induced in Smooth Muscle Cells by Cocultured Endothelial Cells 
 
  In order to examine the functional relationship between vascular smooth muscle 
cells and endothelial cells, our laboratory previously examined expression profiles of 
genes implicated in vascular structure and function20,40–43. In the current study, we 
measured the expression of Cytoglobin in smooth muscle cells that were either cultured 
alone or in the presence of endothelial cells. The culturing of smooth muscle cells and 
endothelial cells in direct contact is referred to as coculture in this study. Human aortic 
and coronary artery smooth muscle cells were cultured for 48 hours followed by cell 
separation using endothelial cell-specific Pecam-1 conjugated beads. Quantitative 
(q)PCR was performed to measure levels of Cytoglobin RNA (Figure 1A). Transcript 
levels of Cytoglobin increased approximately 10-fold in human aortic smooth muscle 
cells that were cocultured with human aortic endothelial cells. Likewise, human coronary 
artery smooth muscle cells demonstrated a significant, yet less pronounced, increase in 
Cytoglobin expression after coculture with human coronary artery endothelial cells. As 
seen in Figure 1A, the difference in fold-increase in Cytoglobin between aortic and 
coronary smooth muscle cells may be explained by the greater basal expression of 
Cytoglobin in coronary smooth muscle cells cultured independently of endothelial cells. 
This suggests that, in coronary artery smooth muscle cells, expression of Cytoglobin is 
endothelial cell independent to a considerable extent. For a more complete analysis, 
Cytoglobin expression was analyzed via detection of Cytoglobin protein by western blot 
in human aortic smooth muscle cells. The pattern of protein expression detected was 
consistent with the observed endothelial cell-dependent induction of Cytoglobin 
transcript. An approximately 3-fold increase in Cytoglobin protein was observed after 
24-hour co-culture, which was increased to approximately 6-fold after 48 hours (Figure 
1B, C). These data demonstrate that endothelial cells are capable of inducing the 
expression of Cytoglobin RNA and protein in vascular smooth muscle cells, suggesting 
a novel means through which endothelial cells govern vascular function.  
 To further investigate the mechanism by which Cytoglobin expression is induced 
in smooth muscle cells by contact with endothelial cells(3), a Notch inhibitor was utilized. 
Smooth muscle cells were incubated in the presence of DAPT which is a Notch inhibitor 
that blocks the activity of gamma secretase, the enzyme responsible for cleaving the 
Notch intracellular signaling domain. Effectively, DAPT prevents the Notch intracellular 
signaling domain from translocating to the nucleus where it acts as a transcriptional 
cofactor1. Incubation with DAPT resulted in the loss of induction of Cytoglobin by 
cocultured endothelial cells (Figure 2). This result suggests that the endothelial-cell 
dependent expression of Cytoglobin in smooth muscle cells is regulated by Notch 
signaling.  
 It is known that Cytoglobin is regulated by hypoxia23. Nitric oxide levels and nitric 
oxide signaling have a role in cellular responses to hypoxia44. Because endothelial cells 
																																																						
(3) Transwell experiments were performed in order to demonstrate that induction was 
mediated by cell-cell contact rather than by an endothelial cell-derived secreted factor56.  
produce ample nitric oxide, we tested whether it might contribute to Cytoglobin 
expression in smooth muscle cells. Neither a nitric oxide donor (DETA-NONOate) nor a 
nitric oxide inhibitor (CPITO) had a significant effect on Cytoglobin expression 
compared to controls (Figure 3). Cobalt chloride is a hypoxia mimic through its 
stabilization of HIF (Hypoxia Inducible Factor), a protein hallmark of hypoxia that is 
stabilized under hypoxic conditions. Upon stabilization, HIF acts as a transcription factor 
for genes involved in angiogenesis, cell survival, metabolism and cell migration45,46. 
Upon culturing smooth muscle cells with the hypoxia mimic cobalt chloride, there was 
significant induction of Cytoglobin expression, as predicted. 
Cytoglobin Expression in Smooth Muscle Cells is Regulated by Notch Signaling  
 Although Notch signaling has been implicated in smooth muscle cell 
differentiation7, the role of Notch is much less defined in the context of vascular 
homeostasis. To explore this and the contribution of Notch receptors in Cytoglobin 
expression, we utilized siRNA to specifically knockdown Notch2 and Notch3 in human 
aortic smooth muscle cells (Figure 4A, B). Notch2 and Notch3 are the predominantly 
expressed Notch receptors in the vasculature and are important for normal vascular 
smooth muscle cell formation and function. Under coculture conditions, we observed 
that Notch2, but not Notch3, was necessary for endothelial cell-induced Cytoglobin 
expression (Figure 4C). Because Notch signaling itself promotes the expression of 
Notch receptors, expression of Notch2 and Notch3 were examined to confirm the 
efficacy of knockdown(4).   
																																																						
(4) Sufficiency of Notch2 and Notch3 to activate Cytoglobin expression was 
demonstrated via lentiviral expression of the Notch intracellular signaling domains 
NICD2 and NICD3 in the absence of endothelial cells56.  
Induction of Cytoglobin by Endothelial Cells Modulates Nitric Oxide 
 Within intact blood vessels, endothelial cells produce nitric oxide that diffuses to 
neighboring smooth muscle cells and asserts control over vascular functions such as 
proliferation and tone47. Recently, Cytoglobin has been implicated in nitric oxide 
metabolism31,48,49. It can be postulated that endothelial cells activate Cytoglobin 
expression in smooth muscle cells to modulate nitric oxide levels.  In order to test 
whether or not Cytoglobin affects nitric oxide levels in smooth muscle cells, we first 
demonstrated the ability to knock down Cytoglobin expression by Cytoglobin specific 
siRNA in aortic smooth muscle cells cultured either alone or in the presence of 
endothelial cells. Efficacy of Cytoglobin ablation was confirmed at the transcript and 
protein level (Figure 5). This knockdown process was later used to investigate the 
difference between nitric oxide levels in smooth muscle cells cultured alone or in 
coculture with endothelial cells in the absence of Cytoglobin(5). 
 
 
 
 
 
 
 
																																																						
(5) Nitric oxide levels were tracked using the DAR-4M reactive dye. Results indicated 
that ablation of Cytoglobin resulted in increased nitric oxide, pointing to a role for 
Cytoglobin in regulating nitric oxide availability and thus contributing to nitric oxide 
function56.  
Figures 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
R
el
at
iv
e 
Ex
pr
es
si
on
CYGB RNAA.
cultured 
alone
co-
cultured
cultured 
alone
co-
cultured
aortic coronary
*
*
0
2
4
6
8
10
 
R
el
at
iv
e 
Ex
pr
es
si
on
CYGB protein
B.
C.
CYGB
TUBB
cultured 
alone
co-
cultured
cultured 
alone
co-
cultured
24h 48h
cultured 
alone
co-
cultured
cultured 
alone
co-
cultured
24h 48h
*
*
Figure 1. Cytoglobin expression is induced in smooth muscle cells by endothelial 
cells. (A) Cytoglobin expression in human aortic smooth muscle cells and human 
coronary artery smooth muscle cells in response to coculture with endothelial cells. 
Smooth muscle cells were cultured either alone or in coculture with aortic/ coronary 
endothelial cells. After 48 hours cell separation was performed to remove endothelial 
cells, RNA was isolated subjected to qPCR. (B) Protein lysate was isolated from human 
aortic smooth muscle cells that were cultured either alone or in coculture with aortic 
endothelial cells. After 24 and 48 hours, smooth muscle cells were separated and 
western blots were performed to detect Cytoglobin and Tubulin (TUBB) protein. (C) 
Cytoglobin protein quantified from three independent western blots. Cytoglobin protein 
levels were standardized with respect to Tubulin. *P < 0.05.  
 
Figure 2 
 
Figure 2. Cytoglobin expression is blocked by Notch inhibition (A) CYGB 
expression when treated with DAPT. Human aortic smooth muscle cells were cultured 
either alone or in co-culture with human aortic endothelial cells and in the presence of 3 
µM, 10 µM or 0 µM DAPT. Smooth muscle cells were separated from endothelial cells 
prior to RNA isolation and qPCR was performed in order to determine the relative 
expression of CYGB RNA transcripts. * P < 0.05 
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Figure 3  
 
Figure 3. Cytoglobin expression is influenced by reactive oxygen species and 
hypoxia mimics.  RNA was isolated from human aortic smooth muscle cells that were 
cultured either alone or in coculture with human aortic endothelial cells. Cells were not 
separated prior to analysis. Cells were subjected to treatment with nitric oxide donor 
(DETA-NONOate) and nitric oxide inhibitor (CPITO), and the hypoxia mimic CoCl2. * P < 
0.05, n.s. = not significant.  
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Figure 4. Cytoglobin expression is inhibited by siRNA. siRNA for Notch2 and 
Notch3 transcripts transfected into human aortic smooth muscle cells cultured alone or 
in coculture with endothelial cells. After 48 hours, cells were separated and RNA was 
isolated from smooth muscle cells. qPCR analysis was performed to assess Notch2 (A), 
Notch3 (B), and Cytoglobin (C), transcript levels under the different conditions. Notch2 
and Notch3 were examined to assess efficiency of knockdown. Notch3 is known to be 
regulated by Notch signaling itself; therefore, a decrease is Notch3 transcript levels 
upon Notch2 as well as Notch3 siRNA knockdown is anticipated. Notch2, on the other 
hand, is not subject to the same regulation by the Notch signaling pathway. *P < 0.05, 
n.s. = not significant.  
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Figure 5. Knockdown of Cytoglobin expression by siRNA. Human aortic smooth 
muscle cells were cultured alone or in coculture with endothelial cells. Cells were 
transfected with either control or Cytoglobin specific siRNA. After 48 hours, smooth 
muscle cells were separated. (A) Cytoglobin transcript levels were measured by qPCR 
from isolated RNA. *P < 0.05. (B) Protein lysates were isolated from the separated 
smooth muscle cells and western blots were performed to asses Cytoglobin protein 
levels, with Tubulin (TUBB) as an internal control.  
 
Discussion  
 Cytoglobin is a hexacoordinate hemoprotein and a member of the ancestral 
globin family which consists of respiratory heme-containing proteins. With other globin 
family members, Cytoglobin shares the ability to bind gaseous ligands such as oxygen, 
carbon monoxide and nitric oxide24,27,28. Cytoglobin expression has been demonstrated 
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in vascular smooth muscle cells, and Cytoglobin has been implicated in the processing 
of nitric oxide, a molecule that plays a critical role in vascular function29. The second 
major cell type comprising functional blood vessels, endothelial cells, is a major source 
of nitric oxide, primarily through the actions of endothelial nitric oxide synthase47. Nitric 
oxide is a key regulator of vascular tone, but the mechanisms by which it regulated have 
yet to be clearly delineated47.  
 Our study found that endothelial cells can induce Cytoglobin expression in 
smooth muscle cells in coculture. These results demonstrate a regulatory role for 
endothelial cells in adjusting smooth muscle cell Cytoglobin levels. Further, we show 
that the Notch signaling pathway is specifically responsible for Cytoglobin induction in 
smooth muscle cells via endothelial cell contact.  
 The Lilly lab has previously demonstrated that endothelial cells possess the 
ability to alter smooth muscle cell gene expression profiles40,42,43,50. There are likely 
several processes and pathways that facilitate this communication between vascular 
endothelial and smooth muscle cells, but the Notch signaling pathway emerges as a key 
contributor. Data demonstrates that endothelial cell derived Notch signaling induces the 
expression of Notch3, syndecan-2, the microRNA 143/145 gene cluster, and smooth 
muscle cell contractile markers such as smooth muscle alpha actin, calponin, and 
smooth muscle 2240,42,43,50–52. The current study identifies Cytoglobin as another protein 
whose expression profile in smooth muscle cells is altered by endothelial cells. Results 
show that Notch signaling is necessary for the induction of Cytoglobin expression. 
Interestingly, specific knockdown of Notch2 and Notch3 identifies a unique role for the 
Notch2 receptor in the induction of Cytoglobin expression. There is no clear explanation  
or significance of the differential role of the Notch2 versus the Notch3 receptor; 
however, previous studies have identified unique functions of the receptors in vascular 
smooth muscle cells. Specifically, the previous research suggests that Notch2 plays an 
anti-proliferative and Notch3 a pro-proliferative and pro-survival role in smooth muscle 
cell function1,53.  
 In general, endothelial cells promote a differentiated, quiescent, and contractile 
smooth muscle cell phenotype. Evidence from this study reveals that endothelial cells 
induce Cytoglobin protein expression in smooth muscle cells through the Notch 
signaling pathway. Based on data shown presently, other experiments performed in our 
lab, and previous research, the ability of endothelial cells to induce Cytoglobin 
expression suggests that endothelial cells are able to influence the vascular smooth 
muscle cell’s ability to process nitric oxide. For example, previous studies have 
identified a significant increase in nitric oxide metabolites in Cytoglobin deficient mice, 
linked the dysregulation of nitric oxide metabolism to Cytoglobin deficiency, and 
postulated the role of Cytoglobin in facilitating the vasodilatory function of nitrite under 
hypoxic conditions32,54,55. Consistent with this, other experiments performed in our lab 
show via direct measurement with DAR-4M reactive dye that nitric oxide levels are 
significantly increased in Cytoglobin deficient smooth muscle cells56. Consequently, 
endothelial cells appear to be able to mediate the capability of smooth muscle cells to 
metabolize nitric oxide. This finding is consistent with endothelial cells’ important role in 
communicating with smooth muscle cells in the vasculature in order to ensure 
homeostasis and proper vascular function in response to environmental stimuli. Further 
studies are required to identify whether or not there exists a precise role for Cytoglobin 
in contributing to vascular pathologies, and whether endothelial-cell derived Notch 
signaling contributes to smooth muscle cell pathologic phenotype modulation and 
disease progression.  
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Introduction  
Cardiac Fibrosis and the Cardiac Fibroblast  
 Heart failure is the final step in the progression of many cardiovascular diseases, 
and heart failure is characterized by interstitial fibrosis, chamber remodeling, and 
reduced ventricular compliance57. Heart disease is a significant global health problem in 
terms of morbidity and mortality as well as health care costs, with average annual costs 
estimated to be greater than $300 billion58. Nearly all etiologies of cardiovascular 
disease involve the dysfunction of cardiac fibroblasts, which engage in persistent, 
pathological tissue repair resulting in excessive extracellular matrix deposition and 
maladaptive scar tissue formation57. Upon injury or stress to the heart, cardiac 
fibroblasts transdifferentiate into a myofibroblast phenotype59. Myofibroblasts are 
essentially a fibroblast-smooth muscle cell hybrid characterized by their ability to 
secrete extracellular matrix, their ability to remodel tissue, and their contractile 
properties60. The activated myofibroblasts in the injured heart begin to accumulate and 
secrete extracellular matrix. Extracellular matrix deposition is proposed to act to 
preserve myocardial structure and functional integrity, which may otherwise be 
compromised due to the loss of injured and necrotic cardiomyocytes61. This normal and 
essential cardiac remodeling becomes pathologic when myofibroblasts accumulate and 
persist in depositing extracellular matrix beyond what is necessary for fibrotic scar 
formation. Pathologic cardiac remodeling by myofibroblasts can result in fibrosis and the 
progression of heart failure62.  
 While persistent fibrotic healing is known to progress heart disease, it is 
challenging to treat due to an incomplete understanding of the molecular regulatory 
pathways that govern fibrosis. The cardiac fibroblast has been implicated as having a 
major role in the pathologic fibrotic healing process, but more research must be done to 
understand the precise mechanistic role of cardiac fibroblasts. There are currently many 
signaling pathways under investigation for their role in regulating myofibroblast 
transformation. One such pathway is the canonical Transforming Growth Factor Beta 
(TGF-ß) signaling pathway involving the SMAD family transcription factors. In TGF-ß 
signaling, SMAD2/3 becomes phosphorylated and interacts with SMAD4. The complex 
then translocates to the nucleus where it is thought to induce transcription of 
myofibroblast genes60. Another pathway is the non-canonical TGF-ß signaling pathway 
which acts through Mitogen Activated Protein Kinase K (MAPKK) to affect the Serum 
Response Factor (SRF) transcription factor. SRF serves to mediate transcription of 
myofibroblast genes60. Additionally, roles for Angiotensin II signaling, Endothelin-1 
signaling, the SRF MRTF-RhoA-GTPase pathway, and receptor protein channels have 
been implicated as summarized in Figure 160,63. 
 
 
 
Figure 1. From 
Davis & Molkentin; 
201460.  
 
 
 
miR-145  
MicroRNA miR-145 is part of a class of non-coding RNA molecules that 
participate in post-transcriptional gene regulation. MicroRNA’s are proposed to engage 
in precise regulation of gene expression with the primary function of dialing-in cellular 
phenotype during processes such as development and differentiation64. Most of the 
current research on miR-145 has involved its expression and function in smooth muscle 
cells, where it has been shown to regulate smooth muscle cells phenotypes65–69. As 
previously noted, smooth muscle cells are not terminally differentiated and can exist in 
multiple phenotypes ranging from contractile to proliferative or synthetic. Switching 
between phenotypes occurs in response to cues or changes from the local 
environment19,70. Collectively, results from established studies demonstrate that miR-
145 (and miR-143, present in the same gene cluster) is highly expressed in contractile 
smooth muscle cells and reduced under proliferative conditions65–69.   
Our lab developed an interest in exploring the molecular pathways that govern 
myofibroblast transformation and cardiac fibrosis after an investigation of the role miR-
145 in vascular smooth muscle cell differentiation. In experiments focusing on miR-145 
expression in smooth muscle cells, it was discovered that induction of miR-145 in 
smooth muscle cells occurred upon co-culture with endothelial cells, was augmented by 
Notch signaling, and was reduced in Notch receptor deficient cells. It was also 
discovered that loss of miR-145 promotes angiotensin-II induced collagen deposition in 
the coronary arteries. Essentially, loss of miR-145 exacerbated induced fibrosis42. 
Further, results from this study showed that TGF-ß is a direct target of miR-145. 
Overexpression of miR-145 resulted in attenuation of extracellular matrix genes 
regulated by TGF-ß Receptor II while 
decreased expression of miR-145 resulted in 
increased extracellular matrix production42. 
Finally, in an attempt to quantify changes in 
TGF-ß signaling, it was found that miR-145 
deficient mouse aortas had a significant 
increase in p38 MAP kinase relative to wild-
type42. Together, these findings provide the 
rationale for the central hypothesis of the 
current study. The central hypothesis is that miR-
145 represses cardiac fibrosis via 
posttranscriptional inhibition of mediators of the fibrotic pathway in cardiac fibroblasts 
(Figure 2)71.  The rationale for this hypothesis is that miR-145 has been found to 
regulate the TGF-ß pathway, the p38 pathway, and the expression of extracellular 
matrix genes in smooth muscle cells. Here, the cardiac fibroblast is studied because 
fibroblasts are the key cell type involved in fibrosis, and the effects of miR-145 are 
proposed to be similar in cardiac fibroblasts compared to smooth muscle cells. 
 Taken with the findings that miR-145 targets TGF-ß signaling to reduce 
extracellular matrix gene expression and that loss of miR-145 exacerbates angiotensin 
II mediated fibrosis, it is reasonable to conclude that miR-145 suppresses TGF-ß-
dependent fibrosis and promotes smooth muscle cell differentiation. In this proposal, 
this reasoning is expanded to suggest a mode of action for miR-145 in cardiac 
fibroblasts that is similar to the mode of action for miR-145 in smooth muscle cells. 
Inducers of  
Cardiac 
Fibrosis 
TGFβ P38 MAP  
kinase 
miR-145 
Fibrotic 
Phenotype 
Figure 1. The central hypothesis is 
that miR-145 functions to repress 
cardiac fibrosis by inhibiting various 
mediators of the fibrotic pathway. 
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Figure 2. Central Hypothesis. Figure via 
Dwitya Sawant71.  
	
Thus, it is hypothesized that miR-145 represses cardiac fibrosis via posttranscriptional 
inhibition of mediators of the fibrotic pathway, specifically TGF-ß and p38 MAP Kinase.   
Generation of RFP-miR-145 Transgenic Mice  
 In order to explore the role of miR-145 in 
cardiac fibrosis, novel RFP-miR-145 transgenic mice 
were generated in the Lilly Laboratory. These mice 
conditionally express an RFP-tagged miR-145 
transgene through Cre-mediated recombination. The 
transgene construct consists of a CAG promoter, LoxP 
sites, RFP, and miR-145 (Figure 3)71. The CAG 
promoter consists of the cytomegalovirus enhancer 
fused to a chicken beta-actin promoter, and is a strong synthetic promoter capable of 
driving high levels of gene expression72,73. The Lox-Stop-Lox cassette consists of a stop 
codon flanked by loxP sites, and is used in order to prevent expression except in the 
case of cre-mediated recombination. Upon the expression of the Cre protein, 
recombination results in removal of the stop codon, allowing for expression of both RFP 
and miR-145.  
 Generation of the transgenic mouse by random knock-in of the genetic construct 
resulted in a variety of lines. Characterization of 
the lines began with phenotypic observations when 
the transgenic mice were crossed with non-
inducible myocardin-Cre mice. Myocardin-Cre 
served to turn on expression of miR-145 
CAG LoxP Stop RFP miR-145LoxP
X
+Cre
CAG RFP miR-145LoxP
Figure 3. Transgene construct –  A 
Cre-Lox system is used to generate 
expression of RFP and miR-145.  via 
Dwitya Sawant71.  
AA 12 7 21.9% 32
AB 10 6 20.7% 29
AC 13 4 13.3% 30
BA 15 0 0.0% 57
BB 11 0 0.0% 29
DA 14 0 0.0% 48
DC 5 7 20.6% 34
EB 14 0 0.0% 28
EA 10 0 0.0% 47
Total 104 24 8.5% 334
Total pupsRFP-miR-145TG/+; MCC/+
% RFP-miR-
145TG/+; MCC/+Line RFP-miR-145TG/+
Figure 4. Phenotypic observations of 
RFP-miR-145 transgenic mice crossed with 
Myocd Cre mice. Data from Jeremy 
Baeten74. 
specifically in cardiac and smooth muscle cells. Viability results are displayed in Figure 
474. The lines highlighted in yellow demonstrated in embryonic lethality. Then, 
expression of miR-145 was examined via embryo gross fluorescence and 
immunostaining. Lines were discarded that showed expression of miR-145 without the 
presence of Cre, that showed inconsistent expression of miR-145, and that lacked 
robust expression. The lines of mice chosen for study based on phenotypic and gene 
expression data were the BB, DA, and AA lines. The BB line was chosen for its 
embryonic lethality, which demonstrates high expression of miR-145 and an important 
role for miR-145 in embryonic development, and its high expression of mature miR-145 
as examined via TaqMan analysis. The AA line was 
chosen because AA x Myocd (Figure 5)71 mice 
survived until two weeks of age, suggesting a more 
moderate expression of miR-145 that could be more 
physiologically relevant. The DA line served as an 
intermediate between the BB and AA line, displaying 
embryonic lethality yet a more moderate expression of miR-145 than the BB line. 
Further study demonstrated inconsistency in RFP and miR-145 expression in the BB 
line, leaving the AA and DA lines for characterization here.  
 A variety of Cre expressing mouse lines were employed to characterize the miR-
145 transgenic mice, including Myocardin (Myocd) Cre and inducible Transcription 
Factor 21 (TCF21) Cre. Highlighted here are the Myocd Cre and the TCF21 Cre. Myocd 
Cre is a valuable tool for characterizing the phenotypes and expression patterns of the 
transgenic mice, and TCF21 is particularly valuable is assessing the function of miR-
CAG LoxP Stop RFP miR-145LoxP
X MCC 
Cre
X
Figure 5. Example Cross of RFP-
miR-145 transgenic mouse with Cre 
expressing mouse71.  
145 in a fibrosis disease model due to the fact that it can be induced after birth of the 
pups.  
 Mice of the Myocd Cre line express Cre protein under the influence of the 
Myocardin promoter. Myocardin is a transcription co-factor of the SRF transcription 
factor, and aids in the regulation of cell proliferation, differentiation and development of 
the cardiovascular system75. This transcription co-factor is expressed in cardiac and 
smooth muscle cells and is necessary for induction of cardiac and smooth muscle gene 
expression. For example, cardiac and smooth muscle cells markers transgelin, Atrial 
Natriuretic Factor, and smoothelins are dependent upon myocardin expression and 
activity for induced or increased expression76–78.  In terms of tissue, Myocardin mRNA is 
apparent in cardiac forming tissues at embryonic day 7.5 and in smooth muscle cell 
tissues at embryonic day 9.5, the time point of murine embryogenesis at which 
vascularization begins78. Myocardin’s early and specific expression patterns make the 
Myocd Cre mice a good option for characterizing the phenotype and expression 
patterns of the AA and DA RFP-miR-145 transgenic mouse lines.  
 The Myocd Cre line, however, is not inducible and results in either embryonic 
lethality or lethality at a mere two weeks of age, making it unsuitable for miR-145 
functional studies in fibrosis disease models. The TCF21 Cre mouse, on the other hand, 
allows for inducible expression of Cre recombinase via the ingestion of tamoxifen and is 
thus better suited for studying the functional role of miR-145. Transcription Factor 21 
(TCF21) is a mesoderm-specific member of the class II bHLH family of transcription 
factors, which are involved in cell fate specification, differentiation, and morphogenesis 
of certain tissues79. One study used reporter activity to examine cell populations 
possessing Cre activity following induction of Cre recombinase by tamoxifen.  Induction 
of Cre activity at post-natal days 5 and 7 resulted in reporter expression in the vast 
majority of interstitial cells, or the cardiac fibroblasts. Hence, inducible TCF21 Cre lines 
can be used to induce RFP-miR-145 expression in cardiac fibroblasts postnatally.    
Characterization of RFP-miR-145 Transgenic Mice  
 The aim of this study is to characterize the role of miR-145 in vascular biology 
and to define the function of miR-145 in a fibrosis disease model. To begin to address 
these aims, we sought to characterize RFP-miR-145 transgenic mouse lines AA and DA 
generated in the Lilly laboratory. The purpose of characterization is to not only delineate 
the role of miR-145 in cardiac development and vascular biology, but also the ensure 
consistent, reproducible expression of the transgene before conducting studies on the 
role miR-145 has in fibrosis.  
 We sought to characterize the transgenic mice by examining phenotype and 
RFP/ miR-145 expression when crossed with Myocd Cre mice.  Both DA and AA 
embryos were collected at various time points (E9.5-E11.5), and AA mice hearts were 
collected upon death at approximately two weeks (DA embryos die in utero). Collected 
tissues were processed and examined. The RFP mRNA and Cre mRNA levels were 
determined via qPCR and miR-145 mature micro RNA expression levels were 
determined via TaqMan analysis. The hearts of two-week-old AA mice were collected, 
processed, and examined via microscopy to examine morphological differences 
between miR-145 expressing and non-expressing mice. We hypothesize that ectopic 
expression of miR-145 would disrupt normal vascular development. Our preliminary 
results reveal expression of the transgene and phenotypically abnormal mutant hearts.  
Materials and Methods  
Quantitative RT-PCR (qPCR)  
Embryos were collected by Dwitya Sawant with assistance80. Total RNA was 
isolated from embryos using RiboZol RNA Extraction Reagent (Ampresco) according to 
the manufacturer’s instructions. RNA was reverse transcribed with M-MLV Reverse 
Transcriptase (Promega) to generate cDNA. Real-Time PCR was performed using the 
StepOne Real Time PCR system by Applied Biosystems. The reporter dye was the 
Power SYBR Green PCR Mastermix and 50 ng of cDNA template was used. The fold 
difference in mRNA levels of the target gene was calculated using the ∆∆CT method 
with normalization to RPL13A mRNA levels. The following are the primer sequences: 
RPL13A, 5’- TCC CTG CTG CTC TCA AGG -3’ (forward) and 5’- GCC CCA GGT AAG 
CAA ACT T -3’ (reverse); 1084 Cre, 5’ – GCG GCT TGG CAG TAA AAA CTA TC -3’ 
(forward) and 1085 Cre, 5’- GTG AAA CAG CAT TGC TGT CAC TT -3’; RFP 145, 5’- 
CCA CCA CCT GTT CTC GTA AT -3’ (forward) and 5’- CGC TGT ATA CAC CCT CTT 
C -3’ (reverse).  
TaqMan Assays  
 Embryos were collected by Dwitya Sawant with assistance80. Total RNA was 
isolated from embryos in the manner described in the qPCR methodology. RNA was 
transcribed with Multiscribe Reverse Transcriptase (Applied Biosystems) using the 
TaqMan MicroRNA Reverse Transcription Kit to generate cDNA. Real-Time PCR was 
performed using the StepOne Real Time PCR system by Applied Biosystems. The 
reporter dye was TaqMan Gene Expression Master Mix (Applied Biosystems).  The fold 
difference in mRNA levels of the target gene was calculated using the ∆∆CT method 
with normalization to U6 snRNA levels. The primers were obtained from TaqMan 
microRNA assays kit by Applied Biosystems: miR-145 (Catalog #002278) and U6 
snRNA (Catalog #001973).  
Mouse Lines, Genotyping, and Crosses 
 All strains were maintained in a C57Bl/6 background. Genotyping of mice and 
embryos was carried out by PCR using the following primers: CreA, 5’- TGC CAC GAC 
CAA GTG ACA GC -3’ and CreB, 5’- CCA GGT TAC GGA TAT AGT TCA TG -3’; 
Internal Control Forward, 5’- CTA GGC CAC AGA ATT GAA AGA TCT -3’ and Internal 
Control Reverse, 5’- GTA GGT GGA AAT TCT AGC ATC ATC C -3’; GT-RFP145-F1, 
5’- TCC CAC AAC GAG GAC TAC A -3’ and GTRFP145-R1, 5’- GCT AAG CCA TGA 
CCT CAA GAA -3’; TCF21F, 5’ TTC TCC AGG CTC AAG ACC AC -3’ and TCF21R, 5’ -
CAA ACC CTA GCA CAA ATC ACT CGC -3’ and TCF21MerP, 5’ –GCT TCC GAT ATC 
CAG ATC CAG AC -3’; miR 145 Forward, 5’ -GCA CGT GCT GAA GGC ATC TCT C -3’ 
and miR-145 Reverse, 5’ –CCT AGA CAG AGG GAG GGT GGG -3’.  
Imaging 
 Tissues were fixed in 4% paraformaldehyde, processed, embedded in paraffin 
and sectioned at 8 micrometers. Sections were treated by hematoxylin and eosin 
staining (Sigma) according to the manufacturer’s protocol.  Tissue fixation, processing, 
embedding, sectioning, and staining procedures were performed by Dwitya Sawant with 
assistance80. Stained sections were imaged using the Zeiss Axio Observer Microscope. 
 
 
 
 
Results and Discussion  
Characterization of the AA Line 
 Analysis of gene expression in RFP and Myocd positive mice revealed an 
induction of Cre and RFP expression in double mutant mice compared to wild type 
mice. Similarly, mature miR-145 transcripts demonstrated an approximately 10-fold 
induction in RFP;Myocd mutants relative to wild type mice. Data from a representative 
litter of AA x Myocd mice is shown in Figure 2. Overall, the AA line demonstrated 
consistent expression of miR-145 when crossed with Myocd expressing mice. The AA 
line mice are viable until approximately two weeks when expressing Myocd. At a 
consistent time point of two weeks and two days, mice expressing both RFP/miR-145 
and Myocd die. The hearts of RFP;Myocd mice have noticeably enlarged atria relative 
to their wild type counterparts (Figure 2A-B).  Both the aortic valves (Figure 2C) and the 
mitral valves (Figure 2D) demonstrate visibly thinner valve leaflets when compared to 
wild type valve leaflets. Further exploration is required to more accurately characterize 
the phenotype of AA pup hearts. 
Characterization of the DA Line 
 The most obvious phenotype of the DA line, when crossed with Myocd, is 
embryonic lethality of RFP/miR-145 and Myocd positive embryos. Gene expression 
analysis of the DA line at embryonic day 9.5 via qPCR and TaqMan analysis produced 
inconsistent results. While both Cre and RFP are highly expressed in mutant strains, 
this expression is not always consistently observed in all mice of the RFP/miR-145 and 
Myocd positive mice. Likewise, miR-145 expression does not appear to be consistently 
or efficiently induced. Data from a representative litter of DA x Myocd mice is displayed 
in Figure 3.  
Summary and Future Directions  
 Overall, the AA line demonstrates a more consistent expression of the miR-145 
transgene relative to the DA line. Moving forward, we will continue to characterize both 
the AA and DA lines using a variety of different lines of Cre mice, including MYH11 Cre 
and TCF21 Cre. Development of the AA mouse hearts, examined at two weeks and two 
days of age, appeared abnormal. Mouse strains that were both RFP/miR-145 and 
Myocd positive demonstrated enlarged atria and thinning of aortic and mitral valve 
leaflets. These abnormalities will be investigated further to analyze the extent and 
prevalence of the phenotype. Further characterization will also include investigating the 
cellular composition of the valves and examining expression of the RFP transgene in 
embryonic hearts and 2-week old hearts by immunostaining. Based on characterization 
thus far, the most likely candidate in which the role of miR-145 in cardiac fibrosis will be 
tested is the AA miR-145 transgenic mouse line but more data will contribute to this 
decision.  
 
 
 
 
 
 
 
Figures 
Figure 1 
 
Figure 1. Expression of AA line x Myocd mouse embryos. Embryos from a cross 
between AA and Myocd mice were dissected at embryonic day 9.580. Data from a 
representative trial is displayed above. The symbol +/+ represents a wild type genotype 
while RFP/Myocd mice are positive for both RFP and Myocd mutant alleles. RNA 
transcripts were isolated from embryonic hearts. Expression of Cre (A) and RFP (B) 
were assessed using qPCR. Expression of mature miR-145 (C) was assessed via 
TaqMan assay. 
Figure 2 
 
Figure 2. Expression of AA line x Myocd mouse embryos. Pups from a cross 
between AA and Myocd mice were dissected at postnatal day 1680. Data from a 
representative trial is displayed above. The symbol +/+ represents a wild type genotype, 
+; Myocd represents mice positive for Myocd but not RFP/miR-145, and RFP/Myocd 
represents mice are positive for RFP/miR-145 and Myocd mutant alleles. Full hearts 
were imaged prior to fixation80 (A) and after fixing, sectioning, and staining with H&E 
(B). Aortic valves (C) and mitral valves (D) were imaged after fixing, sectioning, and 
staining with H&E.  
Figure 3 
 
Figure 3. Expression of DA line x Myocd mouse embryos. Embryos from a cross 
between DA and Myocd mice were dissected at embryonic day 9.580. Data from a 
representative trial is displayed above. The symbol +/+ represents a wild type genotype 
while RFP/Myocd mice are positive for both RFP and Myocd mutant alleles. RNA 
transcripts were isolated from embryonic hearts. Expression of Cre (A) and RFP (B) 
were assessed using qPCR. Expression of mature miR-145 (C) was assessed via 
TaqMan assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion: 
 
Cytoglobin and miR-145, Two Notch Regulated Genes in 
the Cardiovascular System  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 The Notch signaling pathway is an important regulator of vascular development 
and physiology, playing roles in vital processes such as angiogenesis, artery-vein 
differentiation, and regulation of the smooth muscle cell phenotype9. Notch signaling 
operates via cell-to-cell contact, which manifests in the vasculature as ligands on 
endothelial cells interacting with receptors on smooth muscle cells to affect downstream 
signaling. The Lilly Lab, in which I have completed this work, studies the Notch signaling 
pathway to better understand the fundamentals of blood vessel development and 
smooth muscle cell differentiation and phenotype switching.  
 Previous research in the Lilly Lab revealed that the expression of certain genes 
in smooth muscle cells is altered when cocultured with endothelial cells. One of those 
genes was Notch, and it was later uncovered that the Notch signaling pathway operates 
between endothelial cells and smooth muscle cells and contributes to proper 
angiogenesis and phenotypic modulation of smooth muscle cells. Another gene up-
regulated in co-culture was Cytoglobin. The current study aimed to investigate the 
regulation of Cytoglobin by the interactions of endothelial cells and smooth muscle cells 
and to explore the function of Cytoglobin in vascular smooth muscle cells. We 
demonstrate that coculture with endothelial cells induces the expression of Cytoglobin in 
smooth muscle cells. This endothelial cell-derived expression is dependent on the 
Notch signaling pathway, and Notch signaling is required for activation of Cytoglobin 
expression in cocultured smooth muscle cells. Further, our studies revealed a role for 
Cytoglobin in enabling smooth muscle cells to regulate nitric oxide bioavailability and to 
manage vascular derived stress. This cytoprotective role is mediated by endothelial 
cells.  
 Interactions between endothelial cells and smooth muscles cells sparked interest 
in the Lilly Lab in another biomolecule, microRNA miR-145. Previous Lilly Lab findings 
detail the endothelial-derived induction of miR-145 in smooth muscle cells, a process 
which is augmented by Notch signaling and reduced in cells lacking Notch receptors. 
The study also found that miR-145 deficient mice experienced exacerbated angiotensin 
II-induced fibrosis. Turning this result around, we hypothesized that over-expression of 
miR-145 would attenuate angiotensin II-induced fibrosis. Thus, a novel miR-145 
transgenic mouse was created to explore the relationship between miR-145 and cardiac 
fibrosis. The current study aimed to characterize two lines of miR-145 transgenic mice – 
the AA line and the DA line. Although work is still in progress, the AA line presents 
promising results. Embryonic expression of mature miR-145 in mice expressing both 
RFP/ miR-145 and Myocd Cre is increased relative to wild type. Additionally, two-week-
old AA pups demonstrate phenotypic abnormalities of the heart. Moving forward, we will 
continue to characterize the AA and DA lines and investigate the effect that 
overexpression of miR-145 has on angiotensin II-induced cardiac fibrosis. In doing so, 
we may reveal yet another sector of the cardiovascular system in which the Notch 
signaling pathway exerts its influence.  
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